Sequoia Capital

  • DATABASE (699)

  • ARTICLES (372)

    • DATABASE (699)
    • ARTICLES (372)
  • Sort by
    • Relevance
    • Date

Healthcare-focused investment firm Vivo Capital was formed in 1996. Today it has over US$1.8 billion under management, making investments into private and public healthcare companies in the US and Greater China, as well as into promising early-stage innovative healthcare companies.

Founded in October 2014 in Hangzhou, Demonow Capital focuses on local early stage internet startups. In order to better serve startups and entrepreneurs, Demonow set up an incubator to provide early stage startups with professional services.

Based in Shanghai, BA Capital focuses on investments in various consumer sectors. The VC, a subsidiary of Black Ant Group in Shenzhen, was founded in 2016 by three partners Chen Feng, He Yu and Zhang Peiyuan

Horus Capital is a private equity firm founded at the end of 2012. It currently manages over RMB 10bn in assets and is focused on healthcare, AI, media, consumer goods, new materials and energy. The company has invested in about 100 companies. 

Founded in 2012 by Wang Yawei, the former vice-president of China Asset Management and the founder of Top Ace Asset Management, Qianhe Capital provides asset management, equity investment and investment management services. As of April 2017, Qianhe Capital had RMB 24 billion under management and issued 11 trust plans and asset management plans.

Yi Road Capital was founded in Beijing in 2015. 

Founded in 2008 in Shanghai, Stone Capital managed assets over RMB 10 billion in 2017. It focuses on high-growth private enterprises and state-owned companies with special resources in industries such as new material, new energy, high-tech, IT, environmental protection and healthcare.

Established in 2016, Roaming Capital invests mainly in early-stage startups in the sectors of mobile internet, new media, sharing economy, AR/VR, artificial intelligence, etc. The equity funds and digital assets under its management are worth over RMB 2bn. 

Headquartered in Shenzhen, Ren Capital was founded in March 2015 by a group of young entrepreneurs. The VC invests mainly in tech startups and manages assets worth RMB 500m. It offers management expertise to portfolio companies including support for tax planning and IPO preparation.

Founded at the end of 2019, Youshan Capital has raised RMB 3.3bn for its first fund, landing FOF, listed companies, state-owned companies and government guidance funds as its limited partners. It mainly invests in the sectors including TMT, medtech and advanced manufacturing. 

Castel Capital is a privately-owned Dutch venture capital and equity platform. The company also works with co-investors and private family offices to build bespoke investment portfolios. Castel focuses on both tech and non-tech business opportunities across Europe. Seed funding of €100,000–€500,000 and Series A rounds of €500,000–€1 million are generally available for tech deals. Castel has a hands-on management approach and seeks to add value to the portfolio companies. The firm has invested in 10 startups in diverse sectors like digital health, fintech and transportation.

DCP Capital is an international private equity firm that mainly invests in Asia. The DCP team previously led KKR and Morgan Stanley’s private equity businesses in Asia. Over the past 27 years, it has invested in a number of leading enterprises including Ping An Insurance, Mengniu Dairy, CICC and Haier Electronics. Its existing investors include leading sovereign wealth funds, pension funds, endowments, family offices and funds of funds (FOF) across the world.In April 2019, DCP successfully raised over $2bn for its first Greater China-focused USD fund known as DCP Capital Partners I. The fund mainly invests in diverse sectors including consumer goods, industrial technology, healthcare, agrifood, enterprise tech, financial services and technology, media & telecom (TMT).

Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.

Boyu Capital is a China-focused investment firm with offices in Beijing and Hong Kong. It manages tens of billions of US dollars and is one of the largest private equity investment firm in China, and mainly invests in sectors of consumer and retail, financial services, healthcare, media and technology.Boyu Capital was founded in 2011 by the late Ma Xuezheng (died in September 2019), former senior vice-president and financial director of Lenovo Group and managing director and partner of TPG, and Zhang Zixin (Louis Cheung), former general manager of Ping An Insurance. Boyu Capital's first chairman of the board was Jiang Zhicheng (Alvin Jiang), the grandson of former Chinese president Jiang Zemin.

Founded in 2015 by former vice president of Tencent and GM of Tencent M&A, Richard Peng (Peng Zhijian), and former vice GM of Tencent M&A, Kurt Xu, Genesis Capital specializes in growth stage investment of internet startups in China and the US.

Sorry, we couldn’t find any matches for“Sequoia Capital”.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.